These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23915426)

  • 1. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.
    Halloran PF; Pereira AB; Chang J; Matas A; Picton M; De Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    Am J Transplant; 2013 Sep; 13(9):2352-63. PubMed ID: 23915426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).
    Halloran PF; Pereira AB; Chang J; Matas A; Picton M; De Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    Am J Transplant; 2013 Nov; 13(11):2865-74. PubMed ID: 24119109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell-mediated Inflammation.
    Halloran PF; Madill-Thomsen KS; Böhmig GA; Myslak M; Gupta G; Kumar D; Viklicky O; Perkowska-Ptasinska A; Famulski KS;
    Transplantation; 2021 Nov; 105(11):2374-2384. PubMed ID: 34310102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.
    Reeve J; Sellarés J; Mengel M; Sis B; Skene A; Hidalgo L; de Freitas DG; Famulski KS; Halloran PF
    Am J Transplant; 2013 Mar; 13(3):645-55. PubMed ID: 23356949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.
    Reeve J; Chang J; Salazar ID; Lopez MM; Halloran PF
    Am J Transplant; 2016 Apr; 16(4):1183-92. PubMed ID: 26730747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.
    Halloran PF; Potena L; Van Huyen JD; Bruneval P; Leone O; Kim DH; Jouven X; Reeve J; Loupy A
    J Heart Lung Transplant; 2017 Nov; 36(11):1192-1200. PubMed ID: 28662985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Myslak M; Viklicky O; Perkowska-Ptasinska A; Solez K; Halloran PF;
    Transplantation; 2023 May; 107(5):1102-1114. PubMed ID: 36575574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss.
    Halloran K; Parkes MD; Timofte I; Snell G; Westall G; Havlin J; Lischke R; Hachem R; Kreisel D; Levine D; Kubisa B; Piotrowska M; Juvet S; Keshavjee S; Jaksch P; Klepetko W; Hirji A; Weinkauf J; Halloran PF
    J Heart Lung Transplant; 2020 Dec; 39(12):1327-1337. PubMed ID: 32943286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the canonical form of T-cell-mediated rejection in human kidney transplants.
    Famulski KS; Einecke G; Sis B; Mengel M; Hidalgo LG; Kaplan B; Halloran PF
    Am J Transplant; 2010 Apr; 10(4):810-820. PubMed ID: 20132168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies.
    Madill-Thomsen K; Perkowska-Ptasińska A; Böhmig GA; Eskandary F; Einecke G; Gupta G; Halloran PF;
    Am J Transplant; 2020 May; 20(5):1341-1350. PubMed ID: 31846554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation.
    Blydt-Hansen TD; Sharma A; Gibson IW; Mandal R; Wishart DS
    Am J Transplant; 2014 Oct; 14(10):2339-49. PubMed ID: 25138024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of biopsies with "borderline rejection" and prospects for eliminating this category.
    de Freitas DG; Sellarés J; Mengel M; Chang J; Hidalgo LG; Famulski KS; Sis B; Einecke G; Halloran PF
    Am J Transplant; 2012 Jan; 12(1):191-201. PubMed ID: 21992503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ; P'Ng CH; Chapman JR
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.
    Halloran PF; Matas A; Kasiske BL; Madill-Thomsen KS; Mackova M; Famulski KS
    Am J Transplant; 2019 May; 19(5):1356-1370. PubMed ID: 30417539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens.
    Salazar ID; Merino López M; Chang J; Halloran PF
    J Am Soc Nephrol; 2015 Dec; 26(12):3190-8. PubMed ID: 25918035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting CD56+ and CD163+ infiltrates in early versus late renal transplant biopsies.
    Shin S; Kim YH; Cho YM; Park Y; Han S; Choi BH; Choi JY; Han DJ
    Am J Nephrol; 2015; 41(4-5):362-9. PubMed ID: 26087825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
    Halloran PF; Madill-Thomsen K; Aliabadi-Zuckermann AZ; Cadeiras M; Crespo-Leiro MG; Depasquale EC; Deng M; Gökler J; Kim DH; Kobashigawa J; Macdonald P; Potena L; Shah K; Stehlik J; Zuckermann A
    J Heart Lung Transplant; 2022 Mar; 41(3):334-344. PubMed ID: 34548198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of TH2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity?
    Buettner M; Xu H; Böhme R; Seliger B; Jacobi J; Wiesener M; Benz K; Amann K
    Hum Pathol; 2012 Sep; 43(9):1453-62. PubMed ID: 22406372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.
    Halloran PF; Merino Lopez M; Barreto Pereira A
    Am J Transplant; 2016 Mar; 16(3):908-20. PubMed ID: 26743766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.